Skip to main content
Top
Published in: European Journal of Epidemiology 2/2010

Open Access 01-02-2010 | Metabolic Syndrome

Weight change over five-year periods and number of components of the metabolic syndrome in a Dutch cohort

Authors: M. Bot, A. M. W. Spijkerman, J. W. R. Twisk, W. M. M. Verschuren

Published in: European Journal of Epidemiology | Issue 2/2010

Login to get access

Abstract

Overweight and obesity are associated with the metabolic syndrome (MetS). We studied the association of weight change over three consecutive 5-year periods with the number of MetS components in people aged 20–59 years. 5735 participants from the Doetinchem Cohort Study were included. Weight was measured in round 1 and at each 5-year interval follow-up (round 2, 3 and 4). Weight change was defined as the absolute weight change between two consecutive measurements. The number of MetS components (assessed in round 2, 3 and 4) was based on the presence of the following components of the MetS: central obesity, raised blood pressure, reduced high density lipoprotein cholesterol and elevated glucose. Associations of weight change and the number of components of the MetS were analyzed with Generalized Estimating Equations for Poisson regression, stratified for 10-year age groups. For each age group, 1 kg weight gain was positively associated with the number of components of the MetS, independent of sex and measurement round. The association was stronger in 30–39 years (adjusted rate ratio: 1.044; 95%CI: 1.040–1.049) and smaller in older age groups. Compared to stable weight (>−2.5 kg and < 2.5 kg), weight loss (≤−2.5 kg) and weight gain (≥2.5 kg) was associated with a lower and higher rate ratio respectively, for the number of components of the MetS. Our results support the independent association of weight change with the number of MetS components with a more pronounced association in younger people.
Literature
1.
go back to reference Friedman N, Fanning EL. Overweight and obesity: an overview of prevalence, clinical impact, and economic impact. Dis Manag. 2004;7(Suppl 1):S1–6.CrossRefPubMed Friedman N, Fanning EL. Overweight and obesity: an overview of prevalence, clinical impact, and economic impact. Dis Manag. 2004;7(Suppl 1):S1–6.CrossRefPubMed
2.
go back to reference Schokker DF, Visscher TL, Nooyens AC, van Baak MA, Seidell JC. Prevalence of overweight and obesity in the Netherlands. Obes Rev. 2007;8(2):101–8.CrossRefPubMed Schokker DF, Visscher TL, Nooyens AC, van Baak MA, Seidell JC. Prevalence of overweight and obesity in the Netherlands. Obes Rev. 2007;8(2):101–8.CrossRefPubMed
3.
go back to reference Visscher TL, Seidell JC. The public health impact of obesity. Annu Rev Public Health. 2001;22:355–75.CrossRefPubMed Visscher TL, Seidell JC. The public health impact of obesity. Annu Rev Public Health. 2001;22:355–75.CrossRefPubMed
4.
go back to reference Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among US Adults. Diabetes Care. 2004;27(10):2444–9.CrossRefPubMed Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among US Adults. Diabetes Care. 2004;27(10):2444–9.CrossRefPubMed
5.
go back to reference Carnethon MR, Loria CM, Hill JO, Sidney S, Savage PJ, Liu K. Risk factors for the metabolic syndrome: the Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985–2001. Diabetes Care. 2004;27(11):2707–15.CrossRefPubMed Carnethon MR, Loria CM, Hill JO, Sidney S, Savage PJ, Liu K. Risk factors for the metabolic syndrome: the Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985–2001. Diabetes Care. 2004;27(11):2707–15.CrossRefPubMed
6.
go back to reference Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med. 2003;163(4):427–36.CrossRefPubMed Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med. 2003;163(4):427–36.CrossRefPubMed
7.
go back to reference Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595–607.CrossRefPubMed Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595–607.CrossRefPubMed
8.
go back to reference Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49(4):403–14.CrossRefPubMed Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49(4):403–14.CrossRefPubMed
9.
go back to reference Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care. 2003;26(11):3153–9.CrossRefPubMed Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care. 2003;26(11):3153–9.CrossRefPubMed
10.
go back to reference Day C. Metabolic syndrome, or What you will: definitions and epidemiology. Diab Vasc Dis Res. 2007;4(1):32–8.CrossRefPubMed Day C. Metabolic syndrome, or What you will: definitions and epidemiology. Diab Vasc Dis Res. 2007;4(1):32–8.CrossRefPubMed
11.
go back to reference Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106(25):3143–21. Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106(25):3143–21.
12.
go back to reference Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes. 2004;53(8):2087–94.CrossRefPubMed Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes. 2004;53(8):2087–94.CrossRefPubMed
13.
go back to reference Cameron AJ, Boyko EJ, Sicree RA, Zimmet PZ, Söderberg S, Alberti KG, et al. Central obesity as a precursor to the metabolic syndrome in the AusDiab study and Mauritius. Obesity (Silver Spring). 2008;16(12):2707–16.CrossRef Cameron AJ, Boyko EJ, Sicree RA, Zimmet PZ, Söderberg S, Alberti KG, et al. Central obesity as a precursor to the metabolic syndrome in the AusDiab study and Mauritius. Obesity (Silver Spring). 2008;16(12):2707–16.CrossRef
14.
go back to reference Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 1991;34(6):416–22.CrossRefPubMed Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 1991;34(6):416–22.CrossRefPubMed
15.
go back to reference Bos MB, de Vries JH, Wolffenbuttel BH, Verhagen H, Hillege JL, Feskens EJ. The prevalence of the metabolic syndrome in the Netherlands: increased risk of cardiovascular diseases and diabetes mellitus type 2 in one quarter of persons under 60. Ned Tijdschr Geneeskd. 2007;151(43):2382–8.PubMed Bos MB, de Vries JH, Wolffenbuttel BH, Verhagen H, Hillege JL, Feskens EJ. The prevalence of the metabolic syndrome in the Netherlands: increased risk of cardiovascular diseases and diabetes mellitus type 2 in one quarter of persons under 60. Ned Tijdschr Geneeskd. 2007;151(43):2382–8.PubMed
16.
go back to reference Everson SA, Goldberg DE, Helmrich SP, Lakka TA, Lynch JW, Kaplan GA, et al. Weight gain and the risk of developing insulin resistance syndrome. Diabetes Care. 1998;21(10):1637–43.CrossRefPubMed Everson SA, Goldberg DE, Helmrich SP, Lakka TA, Lynch JW, Kaplan GA, et al. Weight gain and the risk of developing insulin resistance syndrome. Diabetes Care. 1998;21(10):1637–43.CrossRefPubMed
17.
go back to reference Ferreira I, Twisk JW, van Mechelen W, Kemper HC, Stehouwer CD. Development of fatness, fitness, and lifestyle from adolescence to the age of 36 years: determinants of the metabolic syndrome in young adults: the Amsterdam growth and health longitudinal study. Arch Intern Med. 2005;165(1):42–8.CrossRefPubMed Ferreira I, Twisk JW, van Mechelen W, Kemper HC, Stehouwer CD. Development of fatness, fitness, and lifestyle from adolescence to the age of 36 years: determinants of the metabolic syndrome in young adults: the Amsterdam growth and health longitudinal study. Arch Intern Med. 2005;165(1):42–8.CrossRefPubMed
18.
go back to reference Hillier TA, Fagot-Campagna A, Eschwege E, Vol S, Cailleau M, Balkau B. Weight change and changes in the metabolic syndrome as the French population moves towards overweight: the DESIR cohort. Int J Epidemiol. 2006;35(1):190–6.CrossRefPubMed Hillier TA, Fagot-Campagna A, Eschwege E, Vol S, Cailleau M, Balkau B. Weight change and changes in the metabolic syndrome as the French population moves towards overweight: the DESIR cohort. Int J Epidemiol. 2006;35(1):190–6.CrossRefPubMed
19.
go back to reference Lloyd-Jones DM, Liu K, Colangelo LA, Yan LL, Klein L, Loria CM, et al. Consistently stable or decreased body mass index in young adulthood and longitudinal changes in metabolic syndrome components: the Coronary Artery Risk Development in Young Adults Study. Circulation. 2007;115(8):1004–11.CrossRefPubMed Lloyd-Jones DM, Liu K, Colangelo LA, Yan LL, Klein L, Loria CM, et al. Consistently stable or decreased body mass index in young adulthood and longitudinal changes in metabolic syndrome components: the Coronary Artery Risk Development in Young Adults Study. Circulation. 2007;115(8):1004–11.CrossRefPubMed
20.
go back to reference Vergnaud AC, Bertrais S, Oppert JM, Maillard-Teyssier L, Galan P, Hercberg S, et al. Weight fluctuations and risk for metabolic syndrome in an adult cohort. Int J Obes. 2008;32(2):315–21.CrossRef Vergnaud AC, Bertrais S, Oppert JM, Maillard-Teyssier L, Galan P, Hercberg S, et al. Weight fluctuations and risk for metabolic syndrome in an adult cohort. Int J Obes. 2008;32(2):315–21.CrossRef
21.
go back to reference Gorber SC, Tremblay M, Moher D, Gorber B. A comparison of direct vs self-report measures for assessing height, weight and body mass index: a systematic review. Obes Rev. 2007;8(4):307–26.CrossRefPubMed Gorber SC, Tremblay M, Moher D, Gorber B. A comparison of direct vs self-report measures for assessing height, weight and body mass index: a systematic review. Obes Rev. 2007;8(4):307–26.CrossRefPubMed
22.
go back to reference Nooyens ACJ, Visscher TLS, Verschuren WMM, Schuit AJ, Boshuizen HC, van Mechelen W, et al. Age, period and cohort effects on body weight and body mass index in adults: The Doetinchem Cohort Study. Public Health Nutr. 2008;24:1–9. Nooyens ACJ, Visscher TLS, Verschuren WMM, Schuit AJ, Boshuizen HC, van Mechelen W, et al. Age, period and cohort effects on body weight and body mass index in adults: The Doetinchem Cohort Study. Public Health Nutr. 2008;24:1–9.
23.
go back to reference Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health. 2007;7(147):220.CrossRefPubMed Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health. 2007;7(147):220.CrossRefPubMed
24.
go back to reference Verschuren W, Blokstra A, Picavet H, Smit H. Cohort profile: The Doetinchem cohort study. Int J Epidemiol. 2008;37(6):1236–41.CrossRefPubMed Verschuren W, Blokstra A, Picavet H, Smit H. Cohort profile: The Doetinchem cohort study. Int J Epidemiol. 2008;37(6):1236–41.CrossRefPubMed
25.
go back to reference Tietz NW, editor. Clinical guide to laboratory tests. 3rd ed. Philadelphia: Pa WB Saunders Company; 1995. p. 268–73. Tietz NW, editor. Clinical guide to laboratory tests. 3rd ed. Philadelphia: Pa WB Saunders Company; 1995. p. 268–73.
26.
go back to reference Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–52.CrossRefPubMed Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–52.CrossRefPubMed
27.
go back to reference Rutten GEHM, De Grauw WIC, Nijpels G, Goudswaard AN, Uitewaal PJM, Van der Does FEE, et al. NHG-Standaard Diabetes mellitus type 2 [Dutch College of General Practitioners Guideline Diabetes mellitus type 2]. Huisarts Wet. 2006;49(3):137–52. Rutten GEHM, De Grauw WIC, Nijpels G, Goudswaard AN, Uitewaal PJM, Van der Does FEE, et al. NHG-Standaard Diabetes mellitus type 2 [Dutch College of General Practitioners Guideline Diabetes mellitus type 2]. Huisarts Wet. 2006;49(3):137–52.
28.
go back to reference Droyvold WB, Midthjell K, Nilsen TI, Holmen J. Change in body mass index and its impact on blood pressure: a prospective population study. Int J Obes (Lond). 2005;29(6):650–5.CrossRef Droyvold WB, Midthjell K, Nilsen TI, Holmen J. Change in body mass index and its impact on blood pressure: a prospective population study. Int J Obes (Lond). 2005;29(6):650–5.CrossRef
29.
go back to reference Czernichow S, Mennen L, Bertrais S, Preziosi P, Hercberg S, Oppert JM. Relationships between changes in weight and changes in cardiovascular risk factors in middle-aged French subjects: effect of dieting. Int J Obes Relat Metab Disord. 2002;26(8):1138–43.CrossRefPubMed Czernichow S, Mennen L, Bertrais S, Preziosi P, Hercberg S, Oppert JM. Relationships between changes in weight and changes in cardiovascular risk factors in middle-aged French subjects: effect of dieting. Int J Obes Relat Metab Disord. 2002;26(8):1138–43.CrossRefPubMed
30.
go back to reference Rainwater DL, Mitchell BD, Comuzzie AG, VandeBerg JL, Stern MP, MacCluer JW. Association among 5-year changes in weight, physical activity, and cardiovascular disease risk factors in Mexican Americans. Am J Epidemiol. 2000;152(10):974–82.CrossRefPubMed Rainwater DL, Mitchell BD, Comuzzie AG, VandeBerg JL, Stern MP, MacCluer JW. Association among 5-year changes in weight, physical activity, and cardiovascular disease risk factors in Mexican Americans. Am J Epidemiol. 2000;152(10):974–82.CrossRefPubMed
31.
go back to reference Norman JE, Bild D, Lewis CE, Liu K, West DS. The impact of weight change on cardiovascular disease risk factors in young black and white adults: the CARDIA study. Int J Obes Relat Metab Disord. 2003;27(3):369–76.CrossRefPubMed Norman JE, Bild D, Lewis CE, Liu K, West DS. The impact of weight change on cardiovascular disease risk factors in young black and white adults: the CARDIA study. Int J Obes Relat Metab Disord. 2003;27(3):369–76.CrossRefPubMed
32.
go back to reference Kraja AT, Borecki IB, North K, Tang W, Myers RH, Hopkins PN, et al. Longitudinal and age trends of metabolic syndrome and its risk factors: the Family Heart Study. Nutr Metab. 2006;3:41.CrossRef Kraja AT, Borecki IB, North K, Tang W, Myers RH, Hopkins PN, et al. Longitudinal and age trends of metabolic syndrome and its risk factors: the Family Heart Study. Nutr Metab. 2006;3:41.CrossRef
33.
go back to reference Kuzuya M, Ando F, Iguchi A, Shimokata H. Age-specific change of prevalence of metabolic syndrome: longitudinal observation of large Japanese cohort. Atherosclerosis. 2007;191(2):305–12.CrossRefPubMed Kuzuya M, Ando F, Iguchi A, Shimokata H. Age-specific change of prevalence of metabolic syndrome: longitudinal observation of large Japanese cohort. Atherosclerosis. 2007;191(2):305–12.CrossRefPubMed
34.
go back to reference Case CC, Jones PH, Nelson K, O’Brian Smith E, Ballantyne CM. Impact of weight loss on the metabolic syndrome. Diabetes Obes Metab. 2002;4(6):407–14.CrossRefPubMed Case CC, Jones PH, Nelson K, O’Brian Smith E, Ballantyne CM. Impact of weight loss on the metabolic syndrome. Diabetes Obes Metab. 2002;4(6):407–14.CrossRefPubMed
35.
go back to reference Elfhag K, Rossner S. Who succeeds in maintaining weight loss? A conceptual review of factors associated with weight loss maintenance and weight regain. Obes Rev. 2005;6(1):67–85.CrossRefPubMed Elfhag K, Rossner S. Who succeeds in maintaining weight loss? A conceptual review of factors associated with weight loss maintenance and weight regain. Obes Rev. 2005;6(1):67–85.CrossRefPubMed
36.
go back to reference Holme I, Sogaard AJ, Haheim LL, Larsen PG, Tonstad S. Repeated Weight Loss is Associated with the Metabolic Syndrome and Diabetes: Results of a 28 Year Re-screening of Men in the Oslo Study. Metab Syndr Relat Disord. 2007;5(2):127–35.CrossRefPubMed Holme I, Sogaard AJ, Haheim LL, Larsen PG, Tonstad S. Repeated Weight Loss is Associated with the Metabolic Syndrome and Diabetes: Results of a 28 Year Re-screening of Men in the Oslo Study. Metab Syndr Relat Disord. 2007;5(2):127–35.CrossRefPubMed
37.
go back to reference Hill JO. Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocr Rev. 2006;27(7):750–61.PubMed Hill JO. Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocr Rev. 2006;27(7):750–61.PubMed
38.
go back to reference Truesdale KP, Stevens J, Lewis CE, Schreiner PJ, Loria CM, Cai J. Changes in risk factors for cardiovascular disease by baseline weight status in young adults who maintain or gain weight over 15 years: the CARDIA study. Int J Obes (Lond). 2006;30(9):1397–407.CrossRef Truesdale KP, Stevens J, Lewis CE, Schreiner PJ, Loria CM, Cai J. Changes in risk factors for cardiovascular disease by baseline weight status in young adults who maintain or gain weight over 15 years: the CARDIA study. Int J Obes (Lond). 2006;30(9):1397–407.CrossRef
39.
go back to reference American Diabetes Association. Postprandial blood glucose. Diabetes Care. 2001;24(4):775–8.CrossRef American Diabetes Association. Postprandial blood glucose. Diabetes Care. 2001;24(4):775–8.CrossRef
Metadata
Title
Weight change over five-year periods and number of components of the metabolic syndrome in a Dutch cohort
Authors
M. Bot
A. M. W. Spijkerman
J. W. R. Twisk
W. M. M. Verschuren
Publication date
01-02-2010
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 2/2010
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-009-9419-7

Other articles of this Issue 2/2010

European Journal of Epidemiology 2/2010 Go to the issue